Literature DB >> 12821859

In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary results.

Hee-Won Kim1, David L Buckley, David M Peterson, G Randy Duensing, Jim Caserta, Jeffrey Fitzsimmons, Stephen J Blackband.   

Abstract

Magnetic resonance (MR) systems operating at 3 Telsa (T) and above have demonstrated considerable potential in human studies, offering improved signal-to-noise ratio and spectral resolution. However, because of radiofrequency limitations and concerns, and the lack of large volume body coils, most studies have been limited to the head. In this study we describe the design and construction of a transceive pelvic phased array coil with which MR images and spectra of the human prostate at 3 T have been obtained. Comparison with 1.5 T instruments with different hardware configurations is difficult; however, in a preliminary comparison the signal-to-noise ratio is improved in phantoms and humans when compared with a 1.5 T receive-only pelvic phased array coil, and high quality spectral resolution is demonstrated through the delineation of the citrate quadruplet in localized 1H prostate spectra. Higher fields offer the potential for MR prostate studies without the use of an endorectal coil.

Entities:  

Mesh:

Year:  2003        PMID: 12821859     DOI: 10.1097/01.RLI.0000065425.29042.8d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  10 in total

Review 1.  [Clinical MR at 3 Tesla: current status].

Authors:  K T Baudendistel; J T Heverhagen; M V Knopp
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

2.  A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation.

Authors:  Robert Toth; Pallavi Tiwari; Mark Rosen; Galen Reed; John Kurhanewicz; Arjun Kalyanpur; Sona Pungavkar; Anant Madabhushi
Journal:  Med Image Anal       Date:  2010-10-28       Impact factor: 8.545

Review 3.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

4.  Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements.

Authors:  Gregory J Metzger; Carl Snyder; Can Akgun; Tommy Vaughan; Kamil Ugurbil; Pierre-Francois Van de Moortele
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

5.  Functional and anatomical differences between continent and incontinent men post radical prostatectomy on urodynamics and 3T MRI: a pilot study.

Authors:  Anne P Cameron; Anne M Suskind; Charlene Neer; Hero Hussain; Jeffrey Montgomery; Jerilyn M Latini; John O DeLancey
Journal:  Neurourol Urodyn       Date:  2014-04-21       Impact factor: 2.696

6.  [Innovative imaging in urology: fascination and future. Yesterday, today, and tomorrow].

Authors:  T Loch; G Schneider
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 7.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

8.  Performance of external and internal coil configurations for prostate investigations at 7 T.

Authors:  Gregory J Metzger; Pierre-Francois van de Moortele; Can Akgun; Carl J Snyder; Steen Moeller; John Strupp; Peter Andersen; Devashish Shrivastava; Tommy Vaughan; Kamil Ugurbil; Gregor Adriany
Journal:  Magn Reson Med       Date:  2010-08-25       Impact factor: 4.668

9.  MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils.

Authors:  Rajakumar Nagarajan; Daniel Ja Margolis; Steven S Raman; David Ouellette; Manoj K Sarma; Robert E Reiter; M Albert Thomas
Journal:  Magn Reson Insights       Date:  2013-05-15

Review 10.  Imaging in genitourinary cancer from the urologists' perspective.

Authors:  P Tsakiris; J de la Rosette
Journal:  Cancer Imaging       Date:  2007-05-28       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.